- Home
- Medical
- Public Health
- Tuberculosis (The Essentials, Fourth Edition)
Tuberculosis (The Essentials, Fourth Edition)
List Price:
$107.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Mario C. Raviglione
Format:
Paperback
Pages:
408
Publisher:
CRC Press (May 31, 2017)
Imprint:
CRC Press
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781138117662
Weight:
19.25oz
Dimensions:
6" x 9"
File:
TAYLORFRANCIS-TayFran_261024042415025-20261024.xml
Folder:
TAYLORFRANCIS
List Price:
$107.99
Country of Origin:
United States
Pub Discount:
30
Series:
Lung Biology in Health and Disease
Case Pack:
10
As low as:
$102.59
Publisher Identifier:
P-CRC
Discount Code:
H
Overview
Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis: The Essentials scrutinizes the new discoveries and observations of the key aspects of the disease. Recognized world experts provide a concise, state-of-the-art review of the 15 essential elements of TBsupply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methodsdiscuss the emerging threat of XDR-TB and the HIV/AIDS factorassess advances in TB research such as new drugs and vaccinesreflect on the progress of the "Stop TB" strategy.
